Ghelardi Emilia, Mazzantini Diletta, Celandroni Francesco, Calvigioni Marco, Panattoni Adelaide, Lupetti Antonella, Bois De Fer Beatrice, Perez Marcos
Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Sanofi, Paris, France.
Front Microbiol. 2023 May 5;14:1127321. doi: 10.3389/fmicb.2023.1127321. eCollection 2023.
Probiotics are living microorganisms that, when administered in adequate amounts, confer a health benefit on the host. Adequate number of living microbes, the presence of specific microorganisms, and their survival in the gastrointestinal (GI) environment are important to achieve desired health benefits of probiotic products. In this study, 21 leading probiotic formulations commercialized worldwide were evaluated for their microbial content and survivability in simulated GI conditions.
Plate-count method was used to determine the amount of living microbes contained in the products. Culture-dependent Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry and culture-independent metagenomic analysis through 16S and 18S rDNA sequencing were applied in combination for species identification. To estimate the potential survivability of the microorganisms contained in the products in the harsh GI environment, an model composed of different simulated gastric and intestinal fluids was adopted.
The majority of the tested probiotic products were concordant with the labels in terms of number of viable microbes and contained probiotic species. However, one product included fewer viable microbes than those displayed on the label, one product contained two species that were not declared, and another product lacked one of the labeled probiotic strains. Survivability in simulated acidic and alkaline GI fluids was highly variable depending on the composition of the products. The microorganisms contained in four products survived in both acidic and alkaline environments. For one of these products, microorganisms also appeared to grow in the alkaline environment.
This study demonstrates that most globally commercialized probiotic products are consistent with the claims described on their labels with respect to the number and species of the contained microbes. Evaluated probiotics generally performed well in survivability tests, although viability of microbes in simulated gastric and intestinal environments showed large variability. Although the results obtained in this study indicate a good quality of the tested formulations, it is important to stress that stringent quality controls of probiotic products should always be performed to provide optimal health benefits for the host.
益生菌是一类活的微生物,当给予足够数量时,能给宿主带来健康益处。足够数量的活微生物、特定微生物的存在以及它们在胃肠道环境中的存活能力对于实现益生菌产品预期的健康益处至关重要。在本研究中,对全球商业化的21种主要益生菌制剂进行了评估,以确定其微生物含量以及在模拟胃肠道条件下的存活能力。
采用平板计数法测定产品中活微生物的数量。将基于培养的基质辅助激光解吸电离飞行时间质谱法与通过16S和18S rDNA测序进行的非培养宏基因组分析相结合,用于菌种鉴定。为了评估产品中所含微生物在恶劣胃肠道环境中的潜在存活能力,采用了由不同模拟胃液和肠液组成的模型。
大多数受试益生菌产品在活菌数量方面与标签一致,且含有益生菌种。然而,有一种产品的活菌数量比标签上显示的少,有一种产品含有两种未声明的菌种,还有一种产品缺少一种标签上标注的益生菌菌株。在模拟酸性和碱性胃肠道液体中的存活能力因产品组成而异。四种产品中的微生物在酸性和碱性环境中均能存活。对于其中一种产品,微生物在碱性环境中似乎也能生长。
本研究表明,大多数全球商业化的益生菌产品在所含微生物的数量和种类方面与标签上描述的一致。评估的益生菌在存活能力测试中总体表现良好,尽管微生物在模拟胃和肠道环境中的活力差异很大。尽管本研究获得的结果表明受试制剂质量良好,但必须强调的是,应始终对益生菌产品进行严格的质量控制,以为宿主提供最佳的健康益处。